title: Basic fibroblast growth factor in human prostate cancer cells.
abstract: To increase our understanding of the potential role of basic fibroblast growth factor (bFGF) in malignant progression of prostate cancer, we determined the production of bFGF, the expression of FGF receptor (flg), and the response to exogenous bFGF in LNCaP, DU 145, and PC 3 cells. We observed that these three prostate cancer cell lines, which differed in their dependence on androgens for growth in vitro and in their in vivo behavior in nude mice, could be distinguished as follows: (a) androgen-sensitive LNCaP cells, which do not metastasize in nude mice, did not produce measurable amounts of bFGF, expressed small but measurable amounts of FGF receptor mRNA, and did respond to exogeneous bFGF; (b) androgen-insensitive, moderately metastatic DU 145 cells did produce measurable amounts of biologically active bFGF, expressed large amounts of FGF receptor mRNA, and responded to exogeneous bFGF and the heparin-binding fractions from DU 145 cell extracts; (c) androgen-insensitive and highly metastatic PC3 cells also produced measurable amounts of bFGF but did not demonstrate a growth response to either the heparin-binding fractions from PC3 cell extracts or exogenous bFGF, even though large amounts of FGF receptor mRNA were expressed in PC 3 cells. These results suggest the possibility that differences in production of, and response to, bFGF may be associated with different biological behavior.
authors.affiliation: Department of Surgery, University of Chicago, Illinois 60637.
authors.forename: T
authors.initials: T
authors.lastname: Nakamoto
authors.forename: C S
authors.initials: CS
authors.lastname: Chang
authors.forename: A K
authors.initials: AK
authors.lastname: Li
authors.forename: G W
authors.initials: GW
authors.lastname: Chodak
mesh_terms: D016475:3T3 Cells; D000818:Animals; D001681:Biological Assay; D015152:Blotting, Northern; D015139:Blotting, Southern; D002417:Cattle; D002455:Cell Division / Q000187:drug effects; D002460:Cell Line; D002846:Chromatography, Affinity; D004261:DNA Replication / Q000187:drug effects; D004273:DNA, Neoplasm / Q000032:analysis / Q000235:genetics; D016222:Fibroblast Growth Factor 2 / Q000032:analysis* / Q000235:genetics / Q000494:pharmacology; D000091344:Filaggrin Proteins; D006801:Humans; D008297:Male; D051379:Mice; D011471:Prostatic Neoplasms / Q000737:chemistry*; D012333:RNA, Messenger / Q000032:analysis / Q000378:metabolism; D011994:Recombinant Proteins / Q000494:pharmacology; D015183:Restriction Mapping; D013936:Thymidine / Q000378:metabolism
chemical_list: D004273:DNA, Neoplasm; C000717249:FLG protein, human; D000091344:Filaggrin Proteins; D012333:RNA, Messenger; D011994:Recombinant Proteins; D016222:Fibroblast Growth Factor 2; D013936:Thymidine